ACTIVE

Cardiovascular Research Center Aalst

Financial year 2025 · Closed on 31/12/2025

Net result-228,2 k €-409,2 %over 1 year
Gross margin173,8 k €-63,6 %over 1 year
Equity793,2 k €-22,3 %over 1 year

Identity

Source · BCE/KBO

Cardiovascular Research Center Aalst is a Non-profit organization incorporated in 1999. Its main activity is: Other business support service activities n.e.c.. Its registered office is in Aalst.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0470.425.452
Incorporation
09/07/1999
Legal form
Non-profit organization
Registered office
Moorselbaan 164
9300 Aalst · FlandreSee on map
Latest accounts
31/12/2025
Joint committees (1)
  • 336
Signals
Solid equityLow riskGood liquidityHealthy social debts

Financials

Source · NBB, 9 filings

Trend over 9 financial years

20252024202320222021
Income statement
Gross margin173,8 k €477,1 k €213,5 k €-486,8 k €-5,4 k €
EBITDA-347,4 k €40,8 k €-115 k €-817,2 k €-207,2 k €
Operating result-349,8 k €34,7 k €-121,1 k €-825,1 k €-215,1 k €
Net result-228,2 k €73,8 k €-56,2 k €-833,2 k €-160,7 k €
Balance sheet
Equity793,2 k €1 M €947,6 k €1 M €1,8 M €
Total assets1,1 M €1,5 M €1,3 M €1,3 M €2 M €
Cash303,6 k €413,5 k €97,4 k €272,6 k €564,4 k €
Debts329,7 k €471,8 k €322,4 k €299,2 k €199,3 k €
Other
Workforce––7,0 ETP6,7 ETP3,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

5 active · 12 ended

Active mandates

Eric Wyffels

Director · since 16 décembre 2019

Active
Ward Heggermont

Director · since 22 décembre 2018

Active
Peter Peytchev

Director · since 22 janvier 2018

Active
Tom De Potter

Director · since 22 janvier 2018

Active
Jozef Bartúnek

Director · since 19 mars 2002

Active

Ended mandates

Emanuele Barbato

Director · since 22 juin 2017

Ended
Marc Vanderheyden

Director · since 22 juin 2017 · until 16 décembre 2019

Ended
Marc Vanderheyden

Director · since 22 juin 2017

Ended
Martin Penicka

Mandate · since 22 juin 2017 · until 22 janvier 2018

Ended

Other companies at this address

Moorselbaan 164 9300 Aalst
CompanyCBE no.
1017.929.183
1017.519.607
1022.351.789
1019.698.840
0760.768.525
0769.516.143
AZORG● Active
1005.154.085
Azorg-ASZ● Active
0686.624.891
0865.982.940
0629.850.791
CARDIO INVEST● Active
1018.122.292
0775.987.330
0725.796.065
0673.662.030
1023.116.012
1013.658.017
Levilo Health● Active
1017.107.752
0690.860.031
NEUROCHIRURGIE● Active
0473.063.555
1017.047.770

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelMicro modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date17/07/202615/07/202512/06/202425/07/202308/07/202220/07/2021
General meeting15/06/202616/06/202503/06/202419/06/202320/06/202221/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 9 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202515/06/202617/07/2026DutchPDF
Micro model31/12/202416/06/202515/07/2025DutchPDF
Abridged model31/12/202303/06/202412/06/2024DutchPDF
Abridged model31/12/202219/06/202325/07/2023DutchPDF
Abridged model31/12/202120/06/202208/07/2022DutchPDF
Abridged model31/12/202021/06/202120/07/2021DutchPDF
Abridged model31/12/201930/06/202027/07/2020DutchPDF
Abridged model31/12/201828/06/201912/08/2019DutchPDF
Abridged model31/12/201731/03/201822/08/2018DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

5 active · 12 ended

Active mandates

Eric Wyffels

Director · since 16 décembre 2019

Active
Ward Heggermont

Director · since 22 décembre 2018

Active
Peter Peytchev

Director · since 22 janvier 2018

Active
Tom De Potter

Director · since 22 janvier 2018

Active
Jozef Bartúnek

Director · since 19 mars 2002

Active

Ended mandates

Emanuele Barbato

Director · since 22 juin 2017

Ended
Marc Vanderheyden

Director · since 22 juin 2017 · until 16 décembre 2019

Ended
Marc Vanderheyden

Director · since 22 juin 2017

Ended
Martin Penicka

Mandate · since 22 juin 2017 · until 22 janvier 2018

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates07/10/2024
    ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates22/07/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates18/07/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates05/12/2017
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates05/01/2015
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other24/06/2011
    BENAMING
    PDF
  • Mandates03/09/2010
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates11/12/2008
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-228,2 k €↓
  2. 2024
    Annual accounts 202473,8 k €↑
  3. 2023
    Annual accounts 2023-56,2 k €↑
  4. 2022
    Annual accounts 2022-833,2 k €↓
  5. 2021
    Annual accounts 2021-160,7 k €↓
  6. 2021
    Name changeCardiovascular Research Center
  7. 2020
    Annual accounts 2020160,3 k €↑
  8. 2019
    Annual accounts 2019135,9 k €↓
  9. 2018
    Annual accounts 2018363,7 k €↓
  10. 2017
    Annual accounts 2017386,4 k €
  11. 2017
    Name changeCardiovascular Research Center Aalst
  12. 09/07/1999
    IncorporationNon-profit organization